MEDP · Medpace Holdings Inc
United States · RS rating 83 · As of 2026-10-14
| Price | 616.63 USD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 64 / 88 / 70 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 46 / 61 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | +21.0% |
| Sales growth Q/Q | +7.4% |
| Distance from 52-week high | +2.1% |
| Market cap (USD) | $11.2B |